(1-azinone) -substituted pyridoindoles as MCH antagonists

Details for Australian Patent Application No. 2009204048 (hide)

Owner Albany Molecular Research, Inc.

Inventors Hadden, Mark; Guzzo, Peter; Henderson, Alan John; Surman, Matthew David; Jiang, May Xiaowu; Grabowski, James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009204048

PCT Pub. Number WO2009/089482

Priority 61/048,677 29.04.08 US; 61/020,530 11.01.08 US

Filing date 9 January 2009

Wipo publication date 16 July 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 521/00 (2006.01) Heterocyclic compounds containing unspecified hetero rings

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/089482 Priority application(s): WO2009/089482

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009204054-Customizable modular multi-function communication device

2009204025-Hydroxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors